liner

pepper gong

# Comprehensive Report: Molecular Mechanism of CRISPR-Cas9 Gene Editing

### Introduction to CRISPR-Cas9

CRISPR-Cas9 is a revolutionary genome editing technology that originated as part of the bacterial adaptive immune system and has been transformed into a powerful tool for genetic engineering. The CRISPR-Cas9 system was originally described as an adaptive immune mechanism that bacteria use to defend against invading viruses ((5)). In its natural context, the system comprises two RNAs and one protein component: a CRISPR RNA (crRNA) that binds complementarily to foreign DNA; a tracrRNA that hybridizes with the crRNA; and a Cas9 enzyme that interacts with the DNA:RNA complexes and cleaves the DNA at a specific site ((5)). This system has been redesigned for gene-editing purposes by combining crRNA and tracrRNA into a chimeric unit called a single guide RNA (sgRNA) and by codon-optimizing the Cas9 enzyme sequence for mammalian expression ((5)). The CRISPR-Cas9 system used for gene editing consists primarily of two components: a guide RNA that detects the specific sequence in the genome and the Cas9 enzyme that binds to the sgRNA and cleaves the DNA at the target site ((1)).

### Structure of the Cas9 Protein

Cas9 from Streptococcus pyogenes is an RNA-guided nuclease that functions by targeting double-stranded DNA (dsDNA) based on guide RNA specificity ((19)). Structurally, Cas9 is composed of two major lobes: the recognition (REC) lobe and the nuclease (NUC) lobe ((19)). The REC lobe contains α-helical domains responsible for binding guide RNA, while the NUC lobe includes the protospacer adjacent motif (PAM)-interacting (PI) domain, HNH, and RuvC domains ((19)). The PI domain is essential for recognizing the PAM sequence in target DNA, which is crucial for Cas9 binding and function ((53)). The HNH and RuvC domains serve as the catalytic centers responsible for cleaving complementary and non-complementary DNA strands, respectively ((135)). This bilobed architecture of Cas9 enables it to perform highly specific DNA targeting and cleavage activities essential for genome editing ((121)).

### Guide RNA Structure and Function

The guide RNA is a critical component that directs Cas9 to specific DNA sequences ((123)). It consists of two components: the CRISPR RNA (crRNA) and trans-activating CRISPR RNA (tracrRNA) ((128)). The crRNA contains an 18-20 base pair sequence that specifies the target DNA by pairing with the target sequence, whereas tracrRNA is a long stretch of loops that serves as a binding scaffold for the Cas9 nuclease ((126)). These two components can be fused to create a single guide RNA (sgRNA), which simplifies the system for laboratory applications ((5)). When introduced into cells, the guide RNA recognizes the intended DNA sequence, and the Cas9 enzyme cuts the DNA at the targeted location ((124)). This recognition is sequence-specific, allowing for precise targeting of particular genomic loci ((129)).

### Target Recognition and Binding Mechanism

The CRISPR-Cas9 target search process begins when Cas9 initially recognizes the PAM in dsDNA using the PI domain ((19)). Upon PAM recognition, Cas9 undergoes conformational changes that facilitate unwinding of the target and non-target DNA strands at the PAM-proximal region through the action of the REC lobe and RuvC domain ((19)). This unwinding enables the annealing of the target DNA strand with the guide RNA strand, forming what is known as an R-loop ((19)). The formation of this R-loop is a critical step that triggers the subsequent cleavage of dsDNA by the HNH and RuvC domains ((19)). The specificity of this process is determined by the complementarity between the crRNA portion of the guide RNA and the target DNA sequence ((127)).

### DNA Cleavage Mechanism by Cas9

Cas9 functions as a metal-dependent nuclease that uses Mg²⁺ to cleave DNA ((131)). The cleavage action is executed by two distinct active sites within Cas9: the RuvC domain and the HNH domain ((133)). These domains generate site-specific nicks on opposite DNA strands ((133)). Specifically, the HNH domain cleaves the DNA strand that is complementary to the guide RNA sequence (target strand), while the RuvC domain cleaves the non-complementary strand (non-target strand) ((136)). This dual-action mechanism results in a double-strand break (DSB) in the target DNA ((132)). The precision of this cleavage is determined by the guide RNA sequence and the presence of the PAM sequence adjacent to the target site ((133)). The Cas9-crRNA complex thus functions as an RNA-guided endonuclease with RNA-directed target sequence recognition and protein-mediated DNA cleavage ((133)).

### Cellular Repair Mechanisms Following DNA Cleavage

After the generation of double-strand breaks (DSBs) by Cas9, they need to be recognized and repaired by evolutionarily conserved cellular DNA repair mechanisms, namely Non-Homologous End Joining (NHEJ) and Homology-Directed Repair (HDR) ((326)). The cell's choice between these repair pathways is not arbitrary, and several factors contribute to the decision-making ((330)). NHEJ is the predominant form of mammalian DNA repair mechanism that successfully joins broken pieces of DNA together ((338)). It is active throughout all stages of the cell cycle and is generally more efficient than HDR ((342)). HDR, on the other hand, is a more precise repair mechanism that relies on homologous sequences to guide the repair process ((340)). It is primarily active during the S and G2 phases of the cell cycle when sister chromatids are available as repair templates ((340)).

### Non-Homologous End Joining (NHEJ) Pathway

NHEJ is an error-prone DNA repair pathway that rejoins broken DNA ends without requiring a template with homologous sequences ((320)). This mechanism often leads to small insertions or deletions (indels), making it ideal for gene knockout studies where disrupting gene function is the goal ((320)). The NHEJ process begins with the binding of the Ku70/Ku80 heterodimer and DNA protein kinase catalytic subunit (DNA-PKcs) to the DSB ((338)). This molecular assembly protects the DNA wound site and maintains the ends in close proximity, which is critical for rejoining the pieces of DNA together ((338)). Following end processing, DNA ligase IV, along with X-ray repair cross-complementing protein 4 (XRCC4) and XRCC4-like factor (XLF), ligates the ends to complete the repair process ((338)). While NHEJ is efficient, it lacks the precision of HDR, limiting its use for more complex genetic modifications ((320)).

### Homology-Directed Repair (HDR) for Precise Gene Editing

HDR is a precise DNA repair mechanism that utilizes homologous sequences to accurately repair DSBs ((321)). Unlike NHEJ, which can lead to indels, HDR uses homologous regions as templates for error-free repair ((321)). The HDR pathway begins with the phosphorylation of H2AX by ATM and ATR, resulting in the localized accumulation of γH2AX at the DNA damage site ((340)). The MRN complex then localizes to the DSB and plays a stabilizing role to inhibit chromosomal breaks ((340)). The 5' exonuclease activity by either MRE11/CtIP (short resection) or Exo1/BLM (long resection) generates 3' single-strand overhangs that are covered by human replication protein A (RPA) ((340)). Rad51, in conjunction with breast cancer 1 and 2 (BRCA1 and 2) proteins, subsequently replaces RPA to form filaments on the DNA, initiating the search for the repair template ((340)). The successful completion of HDR results in the precise incorporation of the donor template sequence at the target site ((322)).

### Using Donor DNA Templates for Precise Gene Editing

For precise gene editing using CRISPR-Cas9, researchers can leverage HDR to introduce specific genetic modifications like gene knockins or precise gene edits ((322)). To achieve this objective, they need to design a donor template wherein the DNA sequence intended for insertion is flanked by arms homologous to the 5' and 3' sites of the DSB ((322)). These donor templates can be in various forms, such as plasmids, viral vectors, bacterial vectors, or artificially synthesized single-stranded oligodeoxynucleotides (ssODNs) ((203)). The choice of donor template depends on factors such as the desired edit, the target cell type, and the delivery method ((204)). Studies show that HDR strategies utilizing single-stranded DNA donor templates are generally more efficient than those with double-stranded DNA templates ((219)).

### Enhancing HDR Efficiency for Precise Gene Editing

Several strategies have been developed to enhance HDR efficiency, which is typically lower than NHEJ ((159)). These approaches can be grouped into four main categories: inhibition of the NHEJ DNA repair pathway, activation of the HDR DNA repair pathway, modification of the DNA donor templates, and optimization of Cas9/sgRNA reagent delivery ((164)). Methods to inhibit NHEJ include using small-molecule compounds like Scr7, which interferes with DNA ligase IV, and DNA-PKc inhibitors, which have shown to increase HDR efficiency by up to 81% in multiple cell lines ((168)). Activation of the HDR pathway can be achieved by overexpressing or stimulating key HDR proteins, such as Rad51 ((192)). The RAD51-stimulatory compound 1 (RS-1) has been shown to enhance HDR activity by up to 11-fold in human cells ((192)).

### Donor Template Optimization Strategies

Optimizing donor templates is another approach to enhance HDR efficiency ((202)). This can involve manipulating the concentration or availability of templates, modifying the structure of templates, selecting appropriate template types, and determining optimal template lengths ((203)). One strategy involves covalently tethering the donor DNA template to the Cas9-guide RNA ribonucleoprotein (RNP) complex, which ensures spatial and temporal co-localization of the DSB machinery and donor DNA ((351)). This approach has demonstrated up to a 30-fold enhancement of HDR using several editing assays, including repair of a frameshift and in-frame insertions of protein tags ((355)). The improved HDR efficiency is observed in multiple cell types and target loci and is more pronounced at low RNP concentrations ((360)).

### Engineering Cas9 for Enhanced Performance

Engineering of the Cas9 protein itself can also improve its performance in genome editing ((22)). One approach involves modifying Cas9 to enhance its ability to slide along DNA, potentially facilitating target search and reducing off-target cleavage ((22)). This can be achieved by reducing sliding friction through the removal of Cas9 residues that interact with DNA or by introducing sliding-promoting elements, such as the basic tail of Nhp6A ((22)). These modifications can significantly enhance the sliding ability of Cas9, potentially improving its target search efficiency ((38)). For example, removing PAM-recognizing arginines in Cas9 (dPAM-dCas9) increased the diffusion coefficient of the sliding mode by ninefold, indicating that these residues interact with DNA and slow down sliding ((28)).

### Applications of CRISPR-Cas9 in Gene Therapy

CRISPR-Cas9-mediated HDR holds tremendous application prospects for gene therapy ((154)). HDR can potentially be used to correct inherited diseases caused by mutant genes through precise genome editing ((157)). It can also enable the insertion of therapeutic transgenes for permanent gene therapy ((158)). Recent advancements in CRISPR-Cas9 delivery methods, such as using adeno-associated virus (AAV) vectors, have shown promising results in in vivo applications ((229)). For instance, AAV9 has been used to deliver sgRNA and a homologous template to Cas9-expressing mice, achieving HDR efficiency in neurons of up to ~15% ((230)). Similarly, HDR efficiency in cardiomyocytes has reached up to ~45% of transduced cells using AAV9 delivery ((231)). These developments highlight the potential of CRISPR-Cas9-mediated HDR for treating genetic disorders ((157)).

### Challenges and Limitations of CRISPR-Cas9 Gene Editing

Despite its potential, CRISPR-Cas9-mediated gene editing faces several challenges ((159)). One major limitation is the low efficiency of HDR, particularly in non-dividing cells ((159)). The relatively high frequency of NHEJ compared to HDR can also hinder precise gene editing ((159)). Additionally, off-target effects, where Cas9 cleaves unintended sites in the genome, remain a concern ((159)). Recent developments to address these challenges include optimizing donor template design, inhibiting competing NHEJ pathways, and ensuring appropriate cell synchronization to increase HDR likelihood ((272)). Another approach involves developing alternative methods such as base editing and prime editing, which can introduce specific changes without requiring DSBs ((279)). However, these alternatives are currently limited to point mutations, small deletions, or insertions ((282)).

### Future Directions in CRISPR-Cas9 Technology

The field of CRISPR-Cas9 gene editing continues to evolve rapidly ((297)). Ongoing research is focused on developing new Cas variants with improved specificity, efficiency, and reduced off-target effects ((284)). For instance, Cas12a has shown potential for increasing both the efficiency of gene knockout by NHEJ and insertion of exogenous donor templates by HDR ((285)). New delivery methods and strategies to enhance HDR efficiency in various cell types, including postmitotic cells, are also being explored ((297)). Interestingly, recent findings suggest that HDR can occur in postmitotic cells, with efficiency comparable to that in mitotic cells, which could expand the applications of HDR-based gene editing ((298)). As the technology advances, CRISPR-Cas9-mediated HDR is expected to make significant contributions to fields ranging from basic research to clinical applications ((299)).

### Conclusion

CRISPR-Cas9 has revolutionized genome editing by providing a programmable and precise tool for modifying DNA sequences ((7)). At the molecular level, the system operates through a sophisticated mechanism involving the recognition of target DNA by guide RNA, cleavage by the Cas9 nuclease, and repair through cellular pathways such as NHEJ and HDR ((5)). While NHEJ is more efficient and results in gene knockouts through indel formation, HDR enables precise genetic modifications when a donor template is provided ((5)). Ongoing research continues to enhance the efficiency, specificity, and versatility of CRISPR-Cas9, expanding its applications in fields such as basic research, agriculture, and human gene therapy ((294)). As our understanding of the molecular mechanisms underlying CRISPR-Cas9 gene editing deepens, so too does our ability to harness its potential for addressing some of the most challenging problems in biology and medicine ((299)).

How does CRISPR-Cas9 work at the molecular level to edit genes?